Evidence map›Paper›PMID 41627900›Full record

ArticleFunction (Oxford, England)2026

Short-term time-restricted feeding improves metabolic rhythms and liver mitochondrial bioenergetic function in high-fat diet-fed mice.

Jennifer A Valcin, Telisha Millender-Swain, Jodi R Paul, Brandon K Collins, Fatme Ghandour, Sameer Al Diffalha, Jennifer S Pollock, David M Pollock, Scott W Ballinger, Karen L Gamble and 1 more

Abstract read
In one paragraph

Article in Function (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jennifer A ValcinDivision of Molecular and Cellular Pathology, Department of Pathology, UAB Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States.
Telisha Millender-SwainDivision of Molecular and Cellular Pathology, Department of Pathology, UAB Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States.
Jodi R PaulDepartment of Psychiatry and Behavioral Neurobiology, UAB Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States.
Brandon K CollinsDivision of Molecular and Cellular Pathology, Department of Pathology, UAB Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States.
Fatme GhandourDivision of Anatomic Pathology, Department of Pathology, UAB Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States.
Sameer Al DiffalhaDivision of Anatomic Pathology, Department of Pathology, UAB Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States.
Jennifer S PollockSection of Cardio-Renal Physiology and Medicine, Division of Nephrology, Department of Medicine, UAB Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States.ORCID 0000-0003-1956-0449
David M PollockSection of Cardio-Renal Physiology and Medicine, Division of Nephrology, Department of Medicine, UAB Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States.
Scott W BallingerDivision of Molecular and Cellular Pathology, Department of Pathology, UAB Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States.
Karen L GambleDepartment of Psychiatry and Behavioral Neurobiology, UAB Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States.
Shannon M BaileyDivision of Molecular and Cellular Pathology, Department of Pathology, UAB Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States.ORCID 0000-0003-0002-3424

Funding

Why is the prevalence of obesity so high in U.S. Southern States? Regional predictors of BMI and obesity treatment response.P30DK056336 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BARBARA A GOWER · 2000 to 2026
$31.9M
Timing of Diet and Kidney Pathophysiology in Diet-Induced ObesityR01DK134562 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI DAVID M POLLOCK, Jennifer S Pollock · 2023 to 2026
$2.6M
Circadian and mitochondrial dysfunction in alcohol-related liver diseaseR01AA029072 · NIAAA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SHANNON MARIE BAILEY · 2023 to 2026
$1.9M
Circadian rhythms and alcohol in the BMAL1 knockout ratR21AA029484 · NIAAA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BAILEY, SHANNON MARIE · 2022 to 2023
$390k
NIAAA NIH HHS R01 AA029072NIAAA NIH HHS R21 AA029484NIDDK NIH HHS P30 DK056336NIDDK NIH HHS R01 DK134562
6 · The paper itself

Abstract

Time-restricted feeding (TRF), which confines food intake to specific time periods without altering nutrient content or reducing calories, has shown promise in improving cardiometabolic health. This study tested whether a 2-wk TRF intervention during the active (dark) period could reverse long-term effects of a high-fat diet (HFD) on liver mitochondrial function, steatosis, and metabolism in mice. Male C57BL/6J mice were fed either a normal-fat diet (NFD, 10% kcal fat) or an HFD (45% kcal fat) ad libitum for 18 wk, followed by 2 wk of active period TRF. Assessments included whole body metabolism, gene expression, histopathology, plasma lipid levels, and mitochondrial bioenergetic function. Chronic HFD feeding abolished the day-night difference in the respiratory exchange ratio (RER), altered 24-h expression rhythms of clock, lipid, and mitochondrial metabolism genes in the liver, and eliminated diurnal variation in liver mitochondrial bioenergetics. TRF partially restored RER rhythmicity without altering body composition or reducing caloric intake in HFD mice. TRF also reset 24-h expression rhythms in clock and several metabolic genes, normalized liver and plasma triglyceride oscillations, and reduced small droplet macrosteatosis in the livers of HFD mice. Importantly, TRF improved liver mitochondrial respiration and reduced circulating levels of mitochondrial transcription factor A, a mitochondrially-derived damage-associated molecule pattern, indicating reduced mitochondrial injury in HFD mice. These findings suggest that TRF can rapidly reverse HFD-induced disruptions in metabolic and mitochondrial function, offering a promising new nonpharmacologic strategy for improving liver health in obesity-related metabolic disease.

Indexed as

Circadian RhythmDiet, High-FatEnergy MetabolismMitochondria, LiverAnimalsFatty LiverIntermittent FastingLipid MetabolismLiverMaleMiceMice, Inbred C57BLcircadian clockhigh-fat dietliver steatosismitochondrial bioenergeticstime-restricted feeding

Identifiers

PMID41627900
PMCPMC13249047

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.